Alcidion Group Ltd

Alcidion Group Ltd

ALC · AU · Healthcare / Health Information Services

0.115AUD+0.01 (+9.52%)

Price History

Full chart

Market Stats

Previous Close0.105
Open0.11
Day Range0.11 – 0.12
52-Week Range0.083 – 0.145
Volume1.72M
Market Cap134.98M
P/E (TTM)0.00
Forward P/E1.26
EPS0.00
Dividend Yield0.00%
Beta1.08
50-Day Avg0.0963
200-Day Avg0.1023

About

Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMs. Kate Quirke
  • Employees141
  • Headquarters9 Yarra Street, South Yarra, VIC, Australia, 3141, Australia
  • Websitehttps://www.alcidion.com

Leadership

  • Ms. Kate QuirkeGroup MD, CEO & Executive Director
  • Mr. Matthew GeppChief Financial Officer
  • Ms. Julia StevensChief Operating Officer
  • Mr. Sean WalkerChief Technology Officer
  • Mr. Nick WhiteChief Marketing Officer
  • Ms. Amanda JamesChief People Officer
  • Ms. Kaye HockingChief Product Officer
  • Dr. Paul DeffleyChief Medical Officer & MD of UK
  • Ms. Tracy McClellandChief Clinical Information Officer
  • Mr. Michael Sapountzis AGIA, B.Com., L.L.B., M.A.I.C.D.Company Secretary

Financials

Income Statement

Currency: AUD2012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue107.62K110.25K2.37M5.18M4.02M3.46M4.18M16.86M18.55M25.88M34.35M40.40M37.06M40.79M51.64M
Growth (%)-+2.44%+2046.92%+118.91%-22.32%-14.08%+20.86%+303.50%+10.00%+39.52%+32.74%+17.60%-8.27%+10.06%+26.61%
Cost of Revenue-4.14M4.57M1.98M1.63M1.18M2.77M10.95M18.15M22.36M31.06M39.15M5.14M4.80M42.48M
Gross Profit107.62K-4.03M-2.20M3.20M2.40M2.28M1.40M5.91M401.23K3.52M3.29M1.25M31.92M35.99M9.16M
Gross Margin100.00%-3651.54%-93.02%61.74%59.57%65.85%33.61%35.05%2.16%13.60%9.59%3.10%86.14%88.24%17.75%
Operating Expense3.22M-3.11M-1.68M3.59M5.10M4.42M3.61M6.04M2.72M3.69M5.02M5.98M39.57M28.18M6.61M
Operating Income-3.11M-916.74K-524.54K-392.17K-2.70M-2.14M-2.21M-125.48K-2.32M-174.00K-1.73M-4.73M-7.65M7.81M2.55M
Operating Margin-2887.93%-831.55%-22.16%-7.57%-67.03%-61.93%-52.88%-0.74%-12.50%-0.67%-5.03%-11.70%-20.63%19.14%4.94%
EBITDA-3.07M-1.95M-276.10K-278.15K-2.45M-3.06M-3.12M-91.80K-3.85M-474.00K-1.58M-1.43M-4.50M1.94M2.55M
EBITDA Margin-2850.70%-1769.67%-11.67%-5.37%-60.77%-88.58%-74.60%-0.54%-20.73%-1.83%-4.61%-3.53%-12.13%4.75%4.94%
Net Income-3.11M-1.19M-148.59K-278.42K-2.54M-2.06M-2.09M-84.17K-3.08M-2.24M-4.41M-3.62M-8.42M1.65M2.29M
Net Income Margin-2887.93%-1082.85%-6.28%-5.37%-63.22%-59.60%-49.99%-0.50%-16.58%-8.67%-12.84%-8.95%-22.71%4.06%4.42%
Interest Expense069.48K4.00K06.81K073.71K15.55K74.39K3.00K68.00K125.00K103.00K81.00K57.00K
Interest Expense % of Total Revenue0.00%63.02%0.17%0.00%0.17%0.00%1.76%0.09%0.40%0.01%0.20%0.31%0.28%0.20%0.11%

Balance Sheet

Currency: AUD2011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets5.75M2.66M4.20M4.04M3.76M8.07M6.83M5.83M24.86M39.43M58.38M128.35M120.68M114.46M115.63M121.88M
Total Liabilities30.11K132.41K26.40K14.33K14.86K1.49M1.41M2.50M11.61M9.70M13.16M34.40M30.52M27.52M27.82M31.01M
Total Equity5.72M2.53M4.18M4.03M3.75M6.57M5.42M3.33M13.24M29.74M45.22M93.95M90.17M86.94M87.80M90.87M
Cash5.45M1.25M3.87M4.02M3.74M5.65M5.33M2.89M3.17M15.95M25.03M17.34M14.64M11.80M17.70M20.64M
Total Debt----1.55M5.10K---315.85K181.00K2.48M2.15M1.70M1.41M814.00K
Net Debt-5.45M-1.25M-3.87M-4.02M-2.19M-5.64M-5.33M-2.89M-3.17M-15.63M-24.85M-14.86M-12.49M-10.10M-16.29M-19.83M

Cash Flow

Currency: AUD2011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-495.97K-2.58M-169.57K-215.19K-284.12K-2.63M-519.42K-1.83M1.99M-2.02M1.54M996.00K169.00K-7.13M5.76M6.85M
Investing Cash Flow-804.48K-130.81K-35.60K369.09K-75.98K5.31M-14.57K-615.62K-1.74M-362.04K-9.84M-59.74M-3.14M-53.00K-125.00K-1.70M
Financing Cash Flow5.30M-35.10K2.82M1.27M1.27M640.51K219.90K31.35K31.35K15.16M17.23M51.33M-616.00K4.34M-764.00K-800.00K
Capital Expenditure804.48K95.81K40.00K75.98K75.98K19.22K14.57K23.86K264.78K123.82K313.00K311.00K454.00K53.00K125.00K226.00K
Free Cash Flow-1.30M-2.68M-209.57K-215.19K-284.12K-2.65M-533.99K-1.85M1.73M-2.14M1.23M685.00K-285.00K-7.18M5.64M6.62M
FCF to OCF262.20%103.71%123.59%100.00%100.00%100.73%102.80%101.31%86.70%106.14%79.74%68.78%-168.64%100.74%97.83%96.70%

Earnings

Report DateFeb 22, 2016Sep 30, 2016Feb 28, 2017Sep 29, 2017Feb 27, 2018Aug 30, 2018Feb 24, 2019Aug 28, 2019Feb 24, 2020Aug 27, 2020Feb 24, 2021Aug 23, 2021Feb 22, 2022Aug 29, 2022Feb 23, 2023Feb 27, 2024May 29, 2024Aug 29, 2024Nov 27, 2024Feb 26, 2025May 28, 2025Aug 27, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.000.000.000.000.000.000.000.00-0.010.000.000.000.000.000.000.000.000.000.00
Surprise-----------------------
Timing---------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--------

Key Statistics & Ratios

Market Cap134.98M
Enterprise Value118.53M
Trailing P/E0.00
Forward P/E1.26
Price / Sales2.61
Price / Book1.52
EPS0.00
Book Value0.068
Revenue (TTM)51.64M
Gross Profit (TTM)41.46M
EBITDA5.34M
Profit Margin4.43%
Operating Margin2.18%
Return on Equity2.56%
Return on Assets1.34%
Shares Outstanding1.35B
Shares Float984.44M
Beta1.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%